Daley, Matthew F.

Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020

Santoli, J. M., Lindley, M. C., DeSilva, M. B., Kharbanda, E. O., Daley, M. F., Galloway, L., Gee, J., Glover, M., Herring, B., Kang, Y., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report

Vaccine Coverage and HesitancyCOVID-19 and healthcare impacts

Cited by 701

Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the advisory committee on immunization practices — United States, June 2021

Gargano, J. W., Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E., Broder, K. R., Gee, J., Weintraub, E., Shimabukuro, T., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report

Viral Infections and Immunology ResearchSARS-CoV-2 and COVID-19 Research

Cited by 587

Addressing parents’ vaccine concerns: a randomized trial of a social media intervention

Daley, M. F., Narwaney, K. J., Shoup, J. A., Wagner, N. M., & Glanz, J. M. (2018) · American Journal of Preventive Medicine

Vaccine Coverage and HesitancySocial Media in Health Education

Cited by 164

Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009‐2015

Saxon, D. R., Iwamoto, S. J., Mettenbrink, C. J., McCormick, E., Arterburn, D., Daley, M. F., Oshiro, C. E., Koebnick, C., Horberg, M., Young, D. R., et al. (2019) · Obesity

Pharmacology and Obesity TreatmentObesity and Health Practices

Cited by 152

Safety and Effectiveness of Longer‐Term Phentermine Use: Clinical Outcomes from an Electronic Health Record Cohort

Lewis, K. H., Fischer, H., Ard, J., Barton, L., Bessesen, D. H., Daley, M. F., Desai, J., Fitzpatrick, S. L., Horberg, M., Koebnick, C., et al. (2019) · Obesity

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 110

Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.

Greene, S. K., Rett, M., Weintraub, E. S., Li, L., Yin, R., Amato, A. A., Ho, D. T., Sheikh, S. I., Fireman, B. H., Daley, M. F., et al. (2012) · American Journal of Epidemiology

Peripheral Neuropathies and DisordersInfluenza Virus Research Studies

Cited by 91

Guillain-Barre Syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-centered analysis in the Vaccine Safety Datalink, 2009-2011.

Greene, S. K., Rett, M. D., Vellozzi, C., Li, L., Kulldorff, M., Marcy, S. M., Daley, M. F., Belongia, E. A., Baxter, R., Fireman, B. H., et al. (2013) · PLoS ONE

Peripheral Neuropathies and DisordersInfluenza Virus Research Studies

Cited by 59

Association between estimated cumulative vaccine antigen exposure through the first 23 months of life and non-vaccine-targeted infections from 24 through 47 months of age.

Glanz, J. M., Newcomer, S. R., Daley, M. F., DeStefano, F., Groom, H. C., Jackson, M. L., Lewin, B. J., McCarthy, N. L., McClure, D. L., Narwaney, K. J., et al. (2018) · JAMA

Immune responses and vaccinationsVaccine Coverage and Hesitancy

Cited by 54

Depletion-of-susceptibles Bias in Analyses of Intra-season Waning of Influenza Vaccine Effectiveness

Ray, G. T., Lewis, N., Klein, N. P., Daley, M. F., Lipsitch, M., & Fireman, B. (2020) · Clinical Infectious Diseases

Influenza Virus Research StudiesVaccine Coverage and Hesitancy

Cited by 48

Cardiometabolic risk factors among 1.3 million adults with overweight or obesity, but not diabetes, in 10 geographically diverse regions of the United States, 2012-2013

Nichols, G. A., Horberg, M., Koebnick, C., Young, D. R., Waitzfelder, B., Sherwood, N. E., Daley, M. F., & Ferrara, A. (2017) · Preventing Chronic Disease

Diabetes, Cardiovascular Risks, and LipoproteinsObesity, Physical Activity, Diet

Cited by 36